Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 GeneticVariation BEFREE Our results thus suggest that fidarestat could be used as a potential chemopreventive drug for intestinal cancers due to APC gene mutations. 28786349

2018

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 GeneticVariation BEFREE These tumors lack deregulation of APC/β-catenin signaling components, which are crucial gatekeepers in common forms of intestinal cancer. 27941798

2017

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker CTD_human Gene Expression Profile of Colon Mucosa after Cytotoxic Insult in wt and Apc-Mutated Pirc Rats: Possible Relation to Resistance to Apoptosis during Carcinogenesis. 27840820

2016

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker CTD_human Sulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis. 26335331

2015

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker BEFREE Studies of tumors from human familial adenomatous polyposis, sporadic colon cancer, and mouse and rat models of intestinal cancer indicate that the majority of early adenomas develop through loss of normal function of the Adenomatous polyposis coli (APC) gene. 22308460

2012

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker CTD_human Crypt stem cells as the cells-of-origin of intestinal cancer. 19092804

2009

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 AlteredExpression BEFREE In this study we set out to test the hypothesis that loss of Rassf1a can cooperate with inactivation of the adenomatous polyposis coli (Apc) gene to accelerate intestinal tumourigenesis using the Apc-Min (Apc(Min/+)) mouse model, as mutational or deletional inactivation of APC is a frequent early event in the genesis of intestinal cancer. 18391979

2008

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker BEFREE The tumor promoting effects of mutations in genes, such as APC, have been demonstrated in cancer cell lines and in mouse models of intestinal cancer; however, the biological effects of most epigenetic events identified in colorectal cancer remain unknown. 18425817

2008

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker CTD_human Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice. 16962818

2006

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker CTD_human Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice. 14706516

2004

Entrez Id: 324
Gene Symbol: APC
APC
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.350 Biomarker CTD_human Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in Apc1638N transgenic mice. 9111214

1997

Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.330 Biomarker BEFREE Mutations in the Wnt/β-catenin pathway are associated with the majority of intestinal cancers, while dysregulation of the Hippo/Yes-Associated Protein (YAP) pathway is an emerging regulator of intestinal tumorigenesis. 27046831

2016

Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.330 Biomarker BEFREE In mouse models, Tgfbr2 inactivation in the intestinal epithelium accelerates the development of malignant intestinal tumors in combination with disruption of the Wnt-β-catenin pathway. 27835699

2016

Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.330 Biomarker BEFREE Based on our findings we suggest that PGE(2) act through PKA to promote β-catenin nuclear translocation and tumor development in Apc(Min/+) mice in vivo, indicating that the direct regulatory effect of PKA on β-catenin nuclear translocation is operative in intestinal cancer. 22168384

2011

Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.330 Biomarker CTD_human Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice. 10223192

1999

Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 AlteredExpression BEFREE In a mouse model of dietary-induced sporadic small and large intestinal cancer in WT mice in which tumor etiology, lag, incidence, and frequency reflect >90% of intestinal cancer in Western societies, dietary-induced risk altered gene expression profiles predominantly in villus cells of the histologically normal mucosa, in contrast to targeting of crypt cells by inheritance of an Apc(1638N) allele or homozygous inactivation of p21(Waf1/cip1), and profiles induced by each risk factor were distinct at the gene or functional group level. 21652773

2011

Entrez Id: 581
Gene Symbol: BAX
BAX
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 Biomarker BEFREE WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer. 21184732

2011

Entrez Id: 581
Gene Symbol: BAX
BAX
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 Biomarker CTD_human Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. 12663524

2003

Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 Therapeutic CTD_human Short chain fatty acids and colon cancer. 12468628

2002

Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 Biomarker CTD_human Short chain fatty acids and colon cancer. 12468628

2002

Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 Biomarker CTD_human Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. 11535846

2001

Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.310 Therapeutic CTD_human Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. 11535846

2001

Entrez Id: 3784
Gene Symbol: KCNQ1
KCNQ1
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.300 Biomarker CTD_human The role of KCNQ1 in mouse and human gastrointestinal cancers. 23975432

2014

Entrez Id: 9971
Gene Symbol: NR1H4
NR1H4
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.300 Biomarker CTD_human Modulation of farnesoid X receptor results in post-translational modification of poly (ADP-ribose) polymerase 1 in the liver. 23178280

2013

Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.300 Biomarker CTD_human Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. 24185511

2013